Search results for "Myocardial revascularization"

showing 10 items of 30 documents

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI…

2001

Summary Background Despite the use of aspirin, there is still a risk of ischaemic events after percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to aspirin, pretreatment with clopidogrel followed by long-term therapy after PCI is superior to a strategy of no pretreatment and short-term therapy for only 4 weeks after PCI. Methods 2658 patients with non-ST-elevation acute coronary syndrome undergoing PCI in the CURE study had been randomly assigned double-blind treatment with clopidogrel (n=1313) or placebo (n=1345). Patients were pretreated with aspirin and study drug for a median of 6 days before PCI during the initial hospital admission, and for a median o…

MaleRiskAcute coronary syndromePrasugrelTiclopidinemedicine.medical_treatmentMyocardial InfarctionCoronary DiseaseDouble-Blind MethodPreoperative CaremedicineMyocardial RevascularizationHumansMyocardial infarctionProspective Studiescardiovascular diseasesAngioplasty Balloon CoronaryAgedProportional Hazards ModelsManagement of acute coronary syndromeAspirinbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedClopidogrelmedicine.diseaseSurvival AnalysisClopidogrelLogistic ModelsTreatment OutcomeAnesthesiaConventional PCIFemalebusinessElinogrelPlatelet Aggregation Inhibitorsmedicine.drug
researchProduct

Limitations of Clinical History for Evaluation of Patients With Acute Chest Pain, Non-Diagnostic Electrocardiogram, and Normal Troponin

2007

Decision making and risk stratification for patients with acute chest pain, nondiagnostic electrocardiogram results, and normal troponin levels are challenging. The aim of this study was to optimize the clinical history for the evaluation of these patients. A total of 1,011 patients presenting to an emergency department were included. The following data were collected: clinical presentation (pain characteristics and number of pain episodes), coronary risk factors, previous ischemic heart disease, and extracardiac vascular disease (peripheral artery disease, stroke, or creatinine >1.4 mg/dl). Two different predictive models were calculated according to the end points: model 1 for 1-year majo…

MaleThoraxChest Painmedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionMyocardial IschemiaRevascularizationRisk AssessmentElectrocardiographySex FactorsRisk FactorsInternal medicineDiabetes MellitusMyocardial RevascularizationHumansMedicineMyocardial infarctionStrokePeripheral Vascular Diseasesmedicine.diagnostic_testbiologybusiness.industryVascular diseaseTroponin IAge FactorsModels CardiovascularEmergency departmentMiddle Agedmedicine.diseaseTroponinHospitalizationStrokeCreatinineAcute DiseaseExercise Testbiology.proteinCardiologyRegression AnalysisFemaleEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American Journal of Cardiology
researchProduct

Sex differences in mortality in stable patients undergoing vasodilator stress cardiovascular magnetic resonance

2021

Abstract Introduction The prognostic value and therapeutic implications of ischemia as derived from vasodilator stress cardiovascular magnetic resonance (CMR) could differ in men and women, but it has not been stablished. Purpose We assessed the influence of the ischemic burden as derived from CMR on the risk of death and the effect of revascularization across sex. Methods We evaluated 6,237 consecutive patients with known or suspected chronic coronary syndrome (CCS). Extensive ischemia was defined as >5 segments with perfusion deficit. Multivariate Cox proportional hazard regression models were used. Results A total of 2,371 (38.0%) patients were women and 583 (9.3%) underwent CMR-r…

MaleTime Factorsmedicine.medical_treatmentCoronary Artery Disease030204 cardiovascular system & hematologyChest pain0302 clinical medicineRisk FactorsMyocardial RevascularizationRisk of mortalityProspective StudiesRegistries1506030212 general & internal medicinemedicine.diagnostic_testMiddle Agedcoronary artery bypassSurvival RateVasodilationCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinePerfusionMRImedicine.medical_specialtychest painVasodilator stressIschemiaMagnetic Resonance Imaging CineLower riskRisk Assessment03 medical and health sciencesSex FactorsInternal medicinemedicineHumansDiseases of the circulatory (Cardiovascular) systemSex DistributionAgedbusiness.industrypercutaneous coronary interventionPercutaneous coronary interventionMagnetic resonance imagingmedicine.diseaseSpainRC666-701Exercise TestbusinessFollow-Up StudiesEuropean Heart Journal
researchProduct

Prognostic implications of dipyridamole cardiac MR imaging: a prospective multicenter registry

2011

Purpose: To evaluate dipyridamole cardiac magnetic resonance (MR) imaging in the prediction of major events (MEs) in patients with ischemic chest pain in a large multicenter registry. Materials and Methods: Institutional ethics committee approval and written informed consent were obtained. A total of 1722 patients who were undergoing cardiac MR imaging for chest pain were included. Wall motion abnormalities (WMAs) at rest, hyperemia perfusion defect (PD), late gadolinium enhancement (LGE), and inducible WMA were analyzed (abnormal if more than one abnormal segment was seen) with the 17-segment model. A cardiac MR categorization was created: category 1, no PD, LGE, or inducible WMA; category…

MaleVasodilator AgentsMyocardial InfarctionMyocardial IschemiaCardiovascular magnetic-resonanceContrast Medialaw.inventionCoronary artery diseaseCoronary-artery-diseaseRandomized controlled triallawMyocardial RevascularizationProspective StudiesRegistriesMyocardial infarctionDipyridamoleMiddle AgedPrognosisManagementDipyridamoleCardiologyFemaleRadiologyArtifactsmedicine.drugChest Painmedicine.medical_specialtyMagnetic Resonance Imaging CineIschemic cascadeStatistics NonparametricAssociationTECNOLOGIA ELECTRONICAPredictive Value of TestsInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingWall motionAgedProportional Hazards ModelsChi-Square DistributionStress perfusionbusiness.industryReproducibility of ResultsIschemic cascademedicine.diseaseMr imagingMyocardial-infarctionDysfunctionCase-Control StudiesReperfusionIschemic chest painbusiness
researchProduct

Effect of invasive treatment on prognosis in non-ST-segment elevation acute coronary syndrome with or without systolic dysfunction.

2010

Introduction and objectives. Few data are available on the use of invasive treatment in patients with non-STsegment elevation acute coronary syndrome (NSTEACS) and systolic dysfunction. The aim of this study was to determine the effect of invasive treatment on the prognosis of patients with NSTEACS, with or without systolic dysfunction. Methods. The study included 972 consecutive patients admitted for NSTEACS (i.e. ST-segment depression or an elevated troponin-I level). Systolic dysfunction was defined as an ejection fraction <50% on transthoracic echocardiography. The primary long-term endpoint was death or myocardial infarction. The effect of invasive treatment on prognosis was evaluated …

Malemedicine.medical_specialtyAcute coronary syndromeEjection fractionbusiness.industrySystolemedicine.medical_treatmentHazard ratioGeneral MedicineRevascularizationmedicine.diseasePrognosisInternal medicineCardiologyClinical endpointMyocardial RevascularizationMedicineST segmentHumansFemaleMyocardial infarctionSystoleAcute Coronary SyndromebusinessAgedRevista espanola de cardiologia
researchProduct

A practical approach with outcome for the prognostic assessment of non-ST-segment elevation chest pain and normal troponin.

2007

Patients with non-ST-elevation chest pain constitute a heterogeneous population. Our aim is to compare the outcome of patients with chest pain, non-ST-segment deviation, and normal troponin, categorized using a risk score, with that of patients with ST depression or troponin increase. A total of 1,449 patients with non-ST-elevation chest pain were evaluated. A validated risk score (using pain characteristics and risk factors) was applied to patients without ST depression or troponin increase. Accordingly, 4 risk categories were defined: group 1, no troponin increase, no ST depression, and risk score3 points (n = 633); group 2, no troponin increase, no ST depression, but risk scoreor = 3 poi…

Malemedicine.medical_specialtyChest painSeverity of Illness IndexAngina PectorisRisk categoryRisk FactorsInternal medicinemedicineMyocardial RevascularizationST segmentHumansAgedST depressionFramingham Risk Scorebiologybusiness.industryMiddle AgedPrognosisTroponinSurvival AnalysisTroponinHeterogeneous populationTreatment OutcomeSpainbiology.proteinCardiologyFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessEmergency Service HospitalFollow-Up StudiesThe American journal of cardiology
researchProduct

Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations.

2021

Over the past 2 decades, chronic total occlusion (CTO) percutaneous coronary intervention has developed into its own subspecialty of interventional cardiology. Dedicated terminology, techniques, devices, courses, and training programs have enabled progressive advancements. However, only a few randomized trials have been performed to evaluate the safety and efficacy of CTO percutaneous coronary intervention. Moreover, several published observational studies have shown conflicting data. Part of the paucity of clinical data stems from the fact that prior studies have been suboptimally designed and performed. The absence of standardized end points and the discrepancy in definitions also prevent…

Malemedicine.medical_specialtyClinical trial protocols as topicmedicine.medical_treatmentPsychological intervention030204 cardiovascular system & hematologySubspecialtylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawPhysiology (medical)MedicineHumansMedical physics030212 general & internal medicineCoronary VesselClinical Trials as TopicInterventional cardiologybusiness.industryClinical study designPercutaneous coronary interventionCoronary VesselsCoronary OcclusionCoronary occlusionEndpoint determination:Myocardial revascularizationObservational studyFemaleCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

Diagnosis of silent coronary ischemia with selective coronary revascularization might improve 2-year survival of patients with critical limb-threaten…

2021

Abstract Background Patients with critical limb-threatening ischemia (CLTI) have had poor long-term survival after lower extremity revascularization owing to coexistent coronary artery disease. A new cardiac diagnostic test, coronary computed tomography-derived fractional flow reserve (FFRCT), can identify patients with ischemia-producing coronary stenosis who might benefit from coronary revascularization. We sought to determine whether the diagnosis of silent coronary ischemia before limb salvage surgery with selective postoperative coronary revascularization can reduce the incidence of adverse cardiac events and improve the survival of patients with CLTI compared with standard care. Metho…

Malemedicine.medical_specialtyTime FactorsComputed Tomography AngiographyCritical IllnessIschemiaFractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentCoronary artery disease03 medical and health sciencesPeripheral Arterial Disease0302 clinical medicineIschemiaPredictive Value of TestsRisk FactorsInternal medicinemedicineMyocardial RevascularizationHumans030212 general & internal medicineMyocardial infarctionProspective StudiesStrokeAgedbusiness.industryHazard ratioCoronary ischemiaMiddle Agedmedicine.diseaseLimb SalvageFractional Flow Reserve MyocardialStenosisTreatment OutcomeCase-Control StudiesAsymptomatic DiseasesCardiologySurgeryFemaleCardiology and Cardiovascular MedicinebusinessJournal of vascular surgery
researchProduct

Prognostic Value of White Blood Cell Count in Acute Myocardial Infarction: Long-Term Mortality

2005

Although traditionally an elevated white blood cell count (WBC), an indicator of systemic inflammation, has been accepted as part of the healing response following acute myocardial infarction (AMI), it has frequently been shown to be a predictor of adverse cardiovascular events. The present study was designed to assess the association between WBC and long-term mortality in AMI patients either with ST-segment elevation (STEMI) or without ST-segment elevation (non-STEMI). Patients and method. The study included 1118 consecutive patients who were admitted with the diagnosis of AMI: 569 non-STEMI and 549 STEMI. The WBC was measured in the 24 hours following admission. Patients were divided into…

Malemedicine.medical_specialtyTime FactorsMyocardial InfarctionSystemic inflammationElectrocardiographyLeukocyte CountRisk FactorsInternal medicineWhite blood cellMyocardial RevascularizationmedicineHumansHospital Mortalitycardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronarySurvival analysisAgedProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryProportional hazards modelHazard ratioGeneral MedicinePrognosismedicine.diseaseSurvival AnalysisSurgerysurgical procedures operativemedicine.anatomical_structureCardiologyRegression AnalysisFemaleLong term mortalitymedicine.symptombusinessElectrocardiographyFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Cardiovascular Events in Moderately to Severely Obese Obstructive Sleep Apnea Patients on Positive Airway Pressure Therapy.

2016

&lt;b&gt;&lt;i&gt;Background:&lt;/i&gt;&lt;/b&gt; In moderately to severely obese patients with obstructive sleep apnea (OSA), the effects of long-term positive airway pressure (PAP) treatment on cardiovascular risk are poorly defined. &lt;b&gt;&lt;i&gt;Purpose:&lt;/i&gt;&lt;/b&gt; To assess the effect of continuous positive airway pressure (CPAP) or noninvasive ventilation (NIV) on the occurrence of cardiovascular events in obese OSA patients. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We performed a noninterventional observational study in obese OSA patients recruited between 2007 and 2010 at the Sleep Center, University of Grenoble, treated with CPAP or NIV, and followed for 5.6 year…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_treatmentMyocardial Infarctionmacromolecular substancesComorbiditySettore MED/10 - Malattie Dell'Apparato Respiratorio030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineSleep and breathingRisk FactorsSeverity of illnessPositive airway pressuremedicineMyocardial RevascularizationHumansContinuous positive airway pressureMyocardial infarctionAngina UnstableObesityAcute Coronary SyndromeStrokeAgedSleep-disordered breathing · Longitudinal studies · Continuous positive airway pressure · Noninvasive ventilation · PrognosisSleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryArrhythmias CardiacMiddle Agedmedicine.diseaseObesityrespiratory tract diseasesObstructive sleep apneaStroke030228 respiratory systemCardiovascular DiseasesAnesthesiaFemalebusinessRespiration; international review of thoracic diseases
researchProduct